Thrombosis management educational programs

ACSShowing 34 of 4

Thrombosis

A New Age in Anticoagulation: Rethinking Secondary Prevention in ACS

8 COMMENTS - Dec 8, 2011 08:37 EST

Drs. Bode, Verheugt, and Fox present their take on new trial data from AHA 2011 and what it will mean for patients after ACS.

Thrombosis

Addressing Gaps in Patient Care: The Importance of Anticoagulation in Secondary Prevention

1 COMMENT - Sep 26, 2011 16:00 EDT

Join Dr. Bhatt and an international panel of experts Drs. Steg, Bode, and Fox in an interactive town hall, filmed at the recent ESC Congress in Paris.

Thrombosis

Combination Therapy or Triple Antiplatelet Therapy?

Jun 23, 2011 15:05 EDT

Join Drs. Bassand and Huber as they discuss the pros and cons of more intense platelet inhibition in patients post-ACS.

Thrombosis

Thinking Beyond Platelet Inhibition: Oral Anticoagulation for Secondary Prevention in ACS

May 6, 2011 14:42 EDT

When dual antiplatelet therapy fails, what are the options? Dr. Verheugt discusses the evolving concepts in secondary prevention of ACS in this clinical update.

Stroke/AFShowing 38 of 8

Thrombosis

New Treatment Options in the Prevention of AF-Related Stroke

Jan 24, 2012 14:30 EST

Individualizing thromboprophylaxis in patients with AF and the role of novel oral anticoagulants are highlighted in cases presented by Dr. Lip.

Thrombosis

Case Scenarios in AF-Related Stroke: Connecting the Dots Between Clinical Trials and Patient Care

2 COMMENTS - Dec 28, 2011 10:48 EST

Drs. Fox, Califf, Connolly, and Patel review key clinical-trial data of novel oral anticoagulants and use real-world case scenarios to discuss strategies on how to best manage patients with AF and other comorbidities.

Thrombosis

Secondary Stroke Prevention in AF: Impact and Burden on Practice and Healthcare Systems

2 COMMENTS - Sep 28, 2011 13:39 EDT

Drs. Eikelboom, Bode, and Hankey discuss how novel anticoagulants will improve outcomes for patients with AF who have had a stroke.

Thrombosis

A New Era in the Management of Atrial Fibrillation: An Update on Oral Anticoagulation

7 COMMENTS - Sep 27, 2011 14:00 EDT

Join our experts, Drs. Braunwald, Wallentin, Califf, Alexander, Giugliano, and Turpie, as they discuss perspectives from ESC 2011 on improving standard of care for patients with atrial fibrillation at risk for stroke.

AF-Related Stroke: Evaluating the Clinical and Economic Impact of New Oral Anticoagulants

Thrombosis

1 COMMENT - Jul 20, 2011 14:40 EDT

Drs. Hacke, Diener, Hennerici, and Norrving discuss new strategies for the secondary prevention of AF-related stroke.

Thrombosis

Atrial Fibrillation: Managing the At-Risk Stroke Population

5 COMMENTS - Apr 21, 2011 13:03 EDT

Drs. Fox, Hacke, and Alberts discuss new strategies for reducing the risk for stroke, the most devastating consequence of AF.

Thrombosis

A Multidisciplinary Approach to AF-Related Stroke: Building a Consensus to Improve Patient Care

2 COMMENTS - Feb 10, 2011 11:00 EST

Our expert panel, Drs. Patel, Camm, and Singer, discuss strategies to reduce the risk for stroke in patients with AF.

Thrombosis

Trial Designs in AF-Related Stroke: How Do They Relate to Real-World Practice?

Jul 19, 2010 13:51 EDT

Join Drs. Hacke and Diener as they give a neurologist's perspective on the potential impact of novel anticoagulants on the risk for stroke in patients with AF.

DVT/VTE/PEShowing 33 of 3

Thrombosis

Breaking Down Symptomatic DVT: Treatment Gaps in Recurrent Disease

Jan 23, 2012 10:50 EST

Novel oral anticoagulants hold the promise of simplifying the treatment of acute and recurrent VTE; Drs. Turpie, Agnelli, and Cohen discuss recent findings.

Thrombosis

VTE Treatment Simplified: Thoughts on Improving Patient Care

Aug 23, 2011 13:00 EDT

Drs. Turpie, Büller, and Weitz discuss late-breaking data on novel oral anticoagulants for the treatment of VTE presented at ISTH in Kyoto, Japan.

Thrombosis

Coagulation Simplified

Jul 29, 2010 16:11 EDT

With a greater understanding of the mechanisms of coagulation, anticoagulant therapy is moving toward targeted therapy with the promise of improved patient outcomes. But are we there yet? Dr Jeffrey Weitz presents a clinical update.

CME provider: Medscape, LLC.

	Yes
	No

ACSShowing 34 of 4

Stroke/AFShowing 38 of 8

DVT/VTE/PEShowing 33 of 3

What's New